Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

COMPLETED

Integrated Research on Acute Malnutrition in Chad

Lead Sponsor:

International Food Policy Research Institute

Collaborating Sponsors:

UNICEF

Association Sahélienne de Recherches Appliquées pour le Développement Durable

Conditions:

Acute Malnutrition in Childhood

Wasting

Eligibility:

All Genders

6-23 years

Phase:

NA

Brief Summary

The IRAM Chad impact evaluation will be based on a cluster randomized controlled trial to study the impact of the integrated and multisectoral services package (PASIM), aimed at reducing the incidence...

Detailed Description

The general objective of the integrated and multisectoral services package (PASIM) is to reduce the incidence and prevalence of wasting through integrated interventions, including, among other things,...

Eligibility Criteria

Inclusion

  • Cohort 1 (home visits):
  • The criteria for inclusion of children in the main cohort are:
  • 6-6.9 months of age
  • Child singleton
  • The mother must live in the study area from the time of inclusion.
  • The consent of the mother or guardian
  • The exclusion criteria are :
  • Congenital malformations that make anthropometric measurements impossible.
  • Mother intends to leave the study area by December 2021.
  • Cohort 2 (health registers-based):
  • The criteria for inclusion in the treatment cohort are :
  • The child is included in a national treatment program.
  • The child is between 6 and 23 months of age at inclusion
  • Child lives in one of the 100 villages in the study area
  • Cohort 3 (home visits):
  • The inclusion criteria for the relapse study are:
  • Child has been successfully treated for wasting (moderate or severe) and has been discharged from the national treatment program within the last 30 days.
  • The child is between 6 and 23 months of age at inclusion.
  • The child is singleton.
  • The mother must live in the study area from the time of inclusion.
  • The consent of the mother or guardian
  • The exclusion criteria are :
  • Congenital malformations that make anthropometric measurements impossible.
  • Mother intends to leave the study area by December 2021.

Exclusion

    Key Trial Info

    Start Date :

    May 3 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 31 2022

    Estimated Enrollment :

    2089 Patients enrolled

    Trial Details

    Trial ID

    NCT04867694

    Start Date

    May 3 2021

    End Date

    May 31 2022

    Last Update

    February 13 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Mongo Health District

    Mongo, Guéra Region, Chad